Global Acute Repetitive Seizures Market Outlook Till, 2018-2025
The global acute repetitive seizures market size is expected to reach USD 3.19 billion by 2025, according to a new report by Radiant Insights, Inc. The report also states that the market will expand at a strong CAGR of 47.8% during the forecast period. Rise in the number of initiatives to increase the awareness about epilepsy is the major factor driving the market. Download free sample copy @ https://www.radiantinsights.com/research/acute-repetitive-seizures-market/request-sample The market is currently led by generic drugs which mainly include oral benzodiazepines (diazepam and lorazepam). Rectal diazepam is the only approved drug for use in U.S. and buccal midazolam in European Union. Other drugs, such as diazepam (oral and intramuscular), midazolam (buccal, intranasal, intramuscular), lorazepam (oral, intranasal, sublingual), and progesterone are majorly used off label. The market is expected to be consolidated with few major companies and high market share. Furthermore...